Literature DB >> 10067783

Testing normal older people three or four times at 1- to 2-year intervals: defining normal variance.

R J Ivnik1, G E Smith, J A Lucas, R C Petersen, B F Boeve, E Kokmen, E G Tangalos.   

Abstract

Normative data were presented that defined the upper and lower standards for deciding if cognitive abilities show reliable change over 2 or more testing occasions when retesting occurs at 1- to 2-year intervals. The Mayo Cognitive Factor Scores (MCFS; G. E. Smith et al., 1994) were analyzed because they permit the quantitation of overall functioning in 5 clinically important cognitive domains: established verbal knowledge, nonverbal reasoning, attention and concentration, new learning, and delayed memory. To the authors' knowledge, this is the first report of both group-level and individual-level data analyses derived from a respectably sized sample of normal persons who have been tested 3 or more times at clinically common test-retest intervals.

Entities:  

Mesh:

Year:  1999        PMID: 10067783     DOI: 10.1037//0894-4105.13.1.121

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  24 in total

Review 1.  Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods.

Authors:  Kevin Duff
Journal:  Arch Clin Neuropsychol       Date:  2012-02-29       Impact factor: 2.813

2.  Measuring cognitive change in older adults: reliable change indices for the Mini-Mental State Examination.

Authors:  A Hensel; M C Angermeyer; S G Riedel-Heller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-18       Impact factor: 10.154

Review 3.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

4.  Neuropsychological subtypes of incident mild cognitive impairment in the Mayo Clinic Study of Aging.

Authors:  Mary M Machulda; Emily S Lundt; Sabrina M Albertson; Walter K Kremers; Michelle M Mielke; David S Knopman; Mark W Bondi; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2019-05-23       Impact factor: 21.566

Review 5.  Neuropsychological assessment of patients with dementing illness.

Authors:  Julie A Fields; Tanis J Ferman; Bradley F Boeve; Glenn E Smith
Journal:  Nat Rev Neurol       Date:  2011-11-01       Impact factor: 42.937

6.  Do people with Alzheimer's disease improve with repeated testing? Unpacking the role of content and context in retest effects.

Authors:  Alden L Gross; Nadia Chu; Loretta Anderson; M Maria Glymour; Richard N Jones
Journal:  Age Ageing       Date:  2018-11-01       Impact factor: 10.668

7.  Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.

Authors:  Mary M Machulda; V Shane Pankratz; Teresa J Christianson; Robert J Ivnik; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Ronald C Petersen
Journal:  Clin Neuropsychol       Date:  2013-09-17       Impact factor: 3.535

8.  Implications of short-term retest effects for the interpretation of longitudinal change.

Authors:  Timothy A Salthouse; Elliot M Tucker-Drob
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

9.  The emergence of cognitive discrepancies in preclinical Alzheimer's disease: a six-year case study.

Authors:  Mark W Jacobson; Dean C Delis; Guerry M Peavy; Spencer R Wetter; Erin D Bigler; Tracy J Abildskov; Mark W Bondi; David P Salmon
Journal:  Neurocase       Date:  2009-04-21       Impact factor: 0.881

10.  Physical exercise, aging, and mild cognitive impairment: a population-based study.

Authors:  Yonas E Geda; Rosebud O Roberts; David S Knopman; Teresa J H Christianson; V Shane Pankratz; Robert J Ivnik; Bradley F Boeve; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Arch Neurol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.